Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FLT1 | P17948 | 6/20 | 0.41 |
| ▸ | FLT4 | P35916 | 6/20 | 0.41 |
| ▸ | KDR | P35968 | 6/20 | 0.41 |
| ▸ | VCP | P55072 | 2/20 | 0.35 |
| ▸ | IMPDH2 | P12268 | 5/20 | 0.34 |
| ▸ | DGAT1 | O75907 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.33 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.33 |
| ▸ | CETP | P11597 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2346870 | 0.93 | FLT1 (0.45) | FLT1FLT4KDRVCPIMPDH2 | |
| SCHEMBL2338367 | 0.79 | ALOX5 (0.47) | FLT1FLT4KDRIMPDH2ALDH1A1 | |
| SCHEMBL10033776 | 0.79 | ALOX5 (0.47) | FLT1FLT4KDRVCPIMPDH2 | |
| SCHEMBL2346522 | 0.67 | ALOX5 (0.48) | FLT1FLT4KDRVCPIMPDH2 | |
| SCHEMBL10033770 | 0.67 | FLT1 (0.42) | FLT1FLT4KDRVCPKMT2A | |
| SCHEMBL2339289 | 0.67 | FLT1 (0.50) | FLT1FLT4KDRIMPDH2ALDH1A1 | |
| SCHEMBL2343197 | 0.66 | ALDH1A1 (0.47) | FLT1FLT4KDRVCPIMPDH2 | |
| SCHEMBL544048 | 0.65 | MAPK14 (0.46) | FLT1FLT4KDRIMPDH2 | |
| SCHEMBL11974549 | 0.65 | GSK3B (0.54) | ALDH1A1MEN1MAPTKMT2A | |
| SCHEMBL10033772 | 0.64 | DGAT1 (0.44) | FLT1FLT4KDRDGAT1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8658659-B2 | Substituted oxazole derivatives and their use as tyrosine kinase inhibitors | AB SCIENCE (FR) | 2014-02-25 | — | — | US | disclosed |
| US-20120108616-A1 | SUBSTITUTED OXAZOLE DERIVATIVES AND THEIR USE AS TYROSINE KINASE INHIBITORS | AB SCIENCE | 2012-05-03 | — | — | US | disclosed |
| US-20080242704-A1 | Substituted Oxazole Derivatives and their Use as Tyrosine Kinase Inhibitors | AB SCIENCE | 2008-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080242704-A1 | Substituted Oxazole Derivatives and their Use as Tyrosine Kinase Inhibitors | KIT, TYRO3, LCK | FLT1 168/4885FLT4 110/4885KDR 240/4885 |
| US-20120108616-A1 | SUBSTITUTED OXAZOLE DERIVATIVES AND THEIR USE AS TYROSINE KINASE INHIBITORS | KIT, FLT3, LTK | FLT1 7/4885FLT4 6/4885KDR 36/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.